marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-06-2024
Soleno Therapeutics Cash Flow 2011-2024 | SLNO
Annual Cash Flow Soleno Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-20.8 M | -27.8 M | -25.2 M | -17.4 M | -11.7 M | -9.95 M | -13.5 M | -10.3 M | -4.48 M | - | - | - |
Depreciation & Amortization |
1.96 M | 1.96 M | 1.95 M | 1.96 M | 1.96 M | 1.61 M | 18.7 K | 108 K | 28.5 K | 42.1 K | - | - |
Accounts Payables |
1.78 M | 3.25 M | 3.49 M | 2 M | 934 K | 633 K | 538 K | 695 K | 987 K | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | 133 K | 156 K | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | 660 K | 551 K | 109 K | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Soleno Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -12.5 M | - | - | - | -6.73 M | - | -15.6 M | -11 M | -6.36 M | - | -20.9 M | -15.5 M | -7.49 M | - | -18.4 M | -12.2 M | -5.66 M | - | -12.3 M | -7.58 M | -3.69 M | - | -7.95 M | -5.27 M | -2.52 M | - | -7.22 M | -5.18 M | -2.18 M | - | -10.8 M | -8.02 M | -3.98 M | - | -6.92 M | -4.06 M | -1.81 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | 490 K | - | - | - | 490 K | - | 1.48 M | 984 K | 492 K | - | 1.47 M | 979 K | 489 K | - | 1.47 M | 977 K | 489 K | - | 1.47 M | 978 K | 489 K | - | 1.47 M | 983 K | 492 K | - | 1.03 M | 570 K | 119 K | - | 1 K | 45 K | 20 K | - | 59 K | 31 K | 15 K | - | 20 K | 14 K | 7 K | - | 32 K | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
6.24 M | 3.72 M | 8.02 M | 3.15 M | - | 3.44 M | 2.78 M | 1.78 M | 2.32 M | 2.41 M | 2.41 M | 3.25 M | 3.86 M | 3.35 M | 4.67 M | 3.49 M | 3.49 M | 3.49 M | 3.49 M | 2 M | 2 M | 2 M | 2 M | 934 K | 934 K | 934 K | 934 K | 633 K | 633 K | 633 K | 633 K | 411 K | 411 K | 411 K | 538 K | 695 K | 695 K | 695 K | 695 K | 987 K | 987 K | 987 K | 987 K | 57.7 K | 58 K | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3 K | 110 K | 3 K | 137 K | 3 K | 133 K | 156 K | 156 K | 156 K | 156 K | - | 37 K | - | - | 150 K | 150 K | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 164 K | 855 K | - | 703 K | 774 K | 660 K | 551 K | 551 K | 551 K | 551 K | 109 K | 109 K | 109 K | 109 K | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency